covid19.figshare.com
      updated 7 april 2020 at 01:08 GMT
Submit or suggest more data

Treatments studied

‍

Findings listed here should only be used for research purposes. No individual should interpret these findings for any self-diagnosis or self-medication without the prior approval from competent international health/medical regulatory agencies.

Substances / Treatments
Proportion

Remdesivir

Darunavir

Chloroquine

Lopinavir

Interferon

74.9%

70.6%

1.1%

8.2%

-

Breakdown from sources

Darunavir

Nelfinavir

Saquinavir

Rosuvastatin

Montelukast

Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning

Ayman Farag Ping Wang Mahmoud Ahmed Hesham Sadek

Preprint
 listed on 
6.4.2020

Aliskiren

Dipyridamole

Mopidamol

Rolitetracycling

Rosuvastatin

Molecular Docking Reveals the Potential of Aliskiren, Dipyridamole, Mopidamol, Rosuvastatin, Rolitetracycline and Metamizole to Inhibit COVID-19 Virus Main Protease

Omar Aly

Preprint
 listed on 
6.4.2020

remdesivir

nafamostat

ribavirin

camptothecin

vinca

Drug Repurposing Approach Targeted Against Main Protease of SARS-CoV-2 Exploiting ‘Neighbourhood Behaviour’ in 3D Protein Structural Space and 2D Chemical Space of Small Molecules

Sohini Chakraborti, Narayanaswamy Srinivasan

Preprint
 listed on 
6.4.2020

Simeprevir

Paritaprevir

Remdesivir

Baricitinib

Comparative Computational Study of SARS-CoV-2 Receptors Antagonists from Already Approved Drugs

Micael Davi Lima de Oliveira, Kelson Mota Teixeira de Oliveira

Preprint
 listed on 
6.4.2020

Nelfinavir

Nelfinavir Is Active Against SARS-CoV-2 in Vero E6 Cells

Zhijian Xu Hangping Yao Jingshan Shen Nanping Wu Yechun Xu Xiangyun Lu weiliang zhu Lan-Juan Li

Preprint
 listed on 
6.4.2020

Lasinavir

Brecanavir

Telinavir

Rotigaptide

Pimelautide

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of COVID-19 Main Protease: A Virtual Drug Repurposing Study

Serdar Durdagi Busecan Aksoydan Berna Dogan Kader Sahin Aida Shahraki

Preprint
 listed on 
6.4.2020

Sildenafil

Ionomycin

Losartan

Nitroglycerin

Bezafibrate

NOS+SARS-CoV-2 Pathogenesis

Roman Gurinovich, Yuliya Buinitskaya

Preprint
 listed on 
6.4.2020

Remdesivir

Sharing vital research to help prevent and treat cases of coronavirus

Wenshe Ray Liu, Megan Hardeman

online resource
 listed on 
30.3.2020

Remdesivir

3CLpro-1

RBD

ACE2

Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV

Jared S. Morse, Tyler Lalonde, Shiqing Xu, Wenshe Liu

preprint
 listed on 
30.3.2020

Ledipasvir

Velpatasvir

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates

Yu Wai Chen Chin-Pang Yiu Kwok-Yin Wong

preperint
 listed on 
30.3.2020

Other related sources

Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2
Vincent J. Munster Friederike Feldmann Brandi Williamson Neeltje van Doremalen Lizzette Perez-Perez Jonathan Schulz Kimberly Meade-White Atsushi Okumura Julie Callison Beniah Brumbaugh Victoria Avanzato Rebecca Rosenke Patrick Hanley Dana Scott Elizabeth Fischer Emmie de Wit
listed on:
April 14, 2020
A NOVEL COMPUTATIONALLY DESIGNED DRUG TO TREAT THE COVID -19 PANDEMIC
Chikoo Cherian
listed on:
April 7, 2020
A new perspective for mitigation of SARS-CoV-2 infection: priming the immune system for attack
Oren Kolodny, Yoav Ram
listed on:
April 6, 2020
HYPOTHESIS BACTERIA VACCINE AGAINST CORONAVIRUS COVID-19.pdf
Paolo Pelini
listed on:
April 6, 2020
Corona Virus Disease (COVID-19) Outbreak and the Strategy for Prevention
Ahmad Naeem Sajed, Kapil Amgain
listed on:
April 6, 2020
G6PD+SARS-CoV-2 Pathogenesis
Yuliya Buinitskaya, Roman Gurinovich
listed on:
April 6, 2020
COVID-19: Teaching Points From the South Korean Experience
Elizabeth A David Young Tae Kim Samina Park Sang-Min Lee Hogeol Ryu Anthony W Kim
listed on:
April 6, 2020
COVID-19 vaccine candidates: Prediction and validation of 174 novel SARS-CoV-2 epitopes
Marek Prachar Sune Justesen Daniel Bisgaard Steen-Jensen Stephan Thorgrimsen Erik Jurgons Ole Winther Frederik Otzen Bagger
listed on:
April 6, 2020
Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations
Junjie Zou Jian Yin Lei Fang Mingjun Yang Tianyuan Wang Weikun Wu Peiyu Zhang
listed on:
March 30, 2020
Data supporting figures, tables and supplementary information in the published article: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou Yan Liu Xiaobo Lei Pei Li Dan Mi Lili Ren Li Guo Ruixuan Guo Ting Chen Jiaxin Hu Zichun Xiang Zhixia Mu Xing Chen Jieyong Chen Keping Hu Qi Jin Jianwei Wang Zhaohui Qian
listed on:
March 30, 2020